<DOC>
	<DOCNO>NCT00002450</DOCNO>
	<brief_summary>The purpose study see give tenofovir DF plus combination anti-HIV drug safe effective .</brief_summary>
	<brief_title>Safety Effectiveness Tenofovir Disoproxil Fumarate ( Tenofovir DF ) Plus Other Anti-HIV Drugs HIV-Infected Patients</brief_title>
	<detailed_description>Patients randomize 2:1 add tenofovir DF daily placebo exist antiretroviral regimen blind manner . Patients stratify accord HIV-1 RNA level , CD4 cell count , number antiretroviral drug take prior study entry . Patients physicians strongly discourage making change antiviral therapy least 24 week post-randomization . After Week 24 , change background antiretroviral therapy permit . At 24 week post-randomization , patient randomize receive placebo cross receive open-label tenofovir DF daily remainder 48-week study . While study drug , patient monitor safety use periodic physical examination serial laboratory test . Additionally , change plasma HIV RNA level CD4 cell count monitor assess antiviral efficacy . At end 48-week study period , patient roll extended dosing tenofovir DF commercially available Gilead Sciences terminate study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Anti-Retroviral Agents</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Have stable antiHIV therapy least 8 week 4 antiHIV drug time study entry . Have viral load ( level HIV blood ) 400 10,000 copies/ml . Have good kidney function . Are 18 65 year old . Agree use barrier method birth control ( condom ) study 30 day . Exclusion Criteria Patients eligible study : Have new AIDSrelated illness diagnose within 30 day study entry . Have serious medical condition , include kidney bone disease , active infection require antibiotic , cancer ( Kaposi 's sarcoma certain skin cancer ) . Have receive vaccine within 30 day study entry . Are unable take medication mouth . Have ever take tenofovir adefovir dipivoxil . Have take certain medication within 30 day study entry , chemotherapy , corticosteroid , medication affect kidney , treatment Kaposi 's sarcoma , certain experimental drug . Abuse alcohol drug . Are pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2000</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Drug Administration Schedule</keyword>
	<keyword>RNA , Viral</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
</DOC>